|
Name |
8-Methyl-1-decene
|
Molecular Formula | C11H22 | |
IUPAC Name* |
8-methyldec-1-ene
|
|
SMILES |
CCC(C)CCCCCC=C
|
|
InChI |
InChI=1S/C11H22/c1-4-6-7-8-9-10-11(3)5-2/h4,11H,1,5-10H2,2-3H3
|
|
InChIKey |
RFSMYVSHKACWAB-UHFFFAOYSA-N
|
|
Synonyms |
8-methyldec-1-ene; 8-Methyl-1-decene; 1-Decene, 8-methyl-; 61142-79-8; 8-Methyl-1-decene #; DTXSID80334799; EN300-1693493
|
|
CAS | 61142-79-8 | |
PubChem CID | 521957 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 154.29 | ALogp: | 5.4 |
HBD: | 0 | HBA: | 0 |
Rotatable Bonds: | 7 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 0.0 | Aromatic Rings: | 0 |
Heavy Atoms: | 11 | QED Weighted: | 0.366 |
Caco-2 Permeability: | -4.381 | MDCK Permeability: | 0.00001570 |
Pgp-inhibitor: | 0.005 | Pgp-substrate: | 0 |
Human Intestinal Absorption (HIA): | 0.003 | 20% Bioavailability (F20%): | 0.091 |
30% Bioavailability (F30%): | 0.531 |
Blood-Brain-Barrier Penetration (BBB): | 0.971 | Plasma Protein Binding (PPB): | 95.76% |
Volume Distribution (VD): | 1.105 | Fu: | 4.42% |
CYP1A2-inhibitor: | 0.938 | CYP1A2-substrate: | 0.559 |
CYP2C19-inhibitor: | 0.579 | CYP2C19-substrate: | 0.595 |
CYP2C9-inhibitor: | 0.535 | CYP2C9-substrate: | 0.868 |
CYP2D6-inhibitor: | 0.147 | CYP2D6-substrate: | 0.433 |
CYP3A4-inhibitor: | 0.432 | CYP3A4-substrate: | 0.167 |
Clearance (CL): | 6.855 | Half-life (T1/2): | 0.214 |
hERG Blockers: | 0.022 | Human Hepatotoxicity (H-HT): | 0.013 |
Drug-inuced Liver Injury (DILI): | 0.033 | AMES Toxicity: | 0.013 |
Rat Oral Acute Toxicity: | 0.032 | Maximum Recommended Daily Dose: | 0.036 |
Skin Sensitization: | 0.941 | Carcinogencity: | 0.121 |
Eye Corrosion: | 0.993 | Eye Irritation: | 0.987 |
Respiratory Toxicity: | 0.328 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000554 | 0.629 | D0Z5BC | 0.375 | ||||
ENC001139 | 0.615 | D0N3NO | 0.238 | ||||
ENC000797 | 0.579 | D0G2KD | 0.227 | ||||
ENC000460 | 0.526 | D00SJE | 0.210 | ||||
ENC000455 | 0.488 | D06NSA | 0.210 | ||||
ENC001131 | 0.477 | D0P1RL | 0.202 | ||||
ENC001130 | 0.476 | D0W0MF | 0.200 | ||||
ENC001596 | 0.468 | D0FD0H | 0.200 | ||||
ENC000850 | 0.468 | D0AY9Q | 0.200 | ||||
ENC000519 | 0.463 | D0ZI4H | 0.198 |